#South Korea #Seoul #K-Beauty #MEDIPEEL #Jason Wi

MEDIPEEL Names Jason Wi as CEO to Accelerate Global Growth

In a significant development within the beauty industry, MEDIPEEL has appointed Jason Wi as its new Chief Executive Officer, aiming to bolster operational excellence and foster strategic growth on a global scale. Owned primarily by Morgan Stanley Private Equity Asia, MEDIPEEL is embarking on a comprehensive restructuring of its worldwide operations under Wi's leadership, focusing on establishing a resilient and scalable operational model that can support sustained international growth.

Jason Wi brings a wealth of experience in strategic consulting and international partnerships, having previously worked with renowned firms like McKinsey & Company and SoftBank Ventures Asia. His career has been marked by a strong record in developing high-growth enterprises and leading their overseas expansions. MEDIPEEL seeks to leverage Wi's extensive expertise and global network to propel its transition into a leading player in the beauty market worldwide.

As part of its refined strategy, MEDIPEEL is shifting from a traditional export-driven model to a more localized, partnership-focused approach. This transition is designed to create a more structured and flexible operating system while simultaneously strengthening the company's core identity as an "efficacy-driven dermatological beauty brand." This approach is expected to enhance MEDIPEEL's competitiveness in sophisticated international markets. With the backing of Morgan Stanley's global resources, combined with Wi's operational insights, the company is poised to establish a robust framework capable of navigating volatile market conditions.

In addition, Wi plans to incorporate artificial intelligence and data-driven operational methodologies at the core of MEDIPEEL’s business. Key initiatives will include optimizing supply chain management and enhancing customer engagement to stimulate long-term operational efficiencies and profitability. "The sustainable success of K-beauty brands on the global stage relies on two essential pillars: a distinctive brand heritage and an institutionalized operating system that supports it," stated Wi. "We will focus on strengthening global strategic alliances while elevating our internal standards, transforming MEDIPEEL into a world-class and trusted beauty platform."

MEDIPEEL serves as the flagship brand of SKINIDEA, which is owned by MDP Holdings—an investment company under Morgan Stanley PE Asia. SKINIDEA is well-regarded for its innovative products that integrate high-quality ingredients with patented dermatological technologies. With exports to over 75 countries, SKINIDEA develops high-performance skincare solutions based on extensive research and clinical trials, ensuring immediate and lasting improvements tailored to various skin types.

As part of this significant transition, the industry will be watching closely to see how Jason Wi and MEDIPEEL harness their collective expertise and strategic vision to redefine beauty standards and operational excellence across the globe.